Increasing Minority Group Participation in Clinical Trials a Randomized Controlled Study of an Office-based Educational Video
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Clinical Trial
- Sponsor
- Vanderbilt University Medical Center
- Enrollment
- 63
- Locations
- 1
- Primary Endpoint
- study feasibility
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
This study will measure the effects of an office-based, clinical trial education video on clinical trial knowledge and enrollment in clinical trials, in a clinical sample with no previous history of clinical trial participation. This study will also determine the feasibility of implementing an office-based video educational program.
Detailed Description
Clinical trials are essential to scientific discovery and are critical to translating research in to practice. Despite their significance, clinical trial participation rates remain low, especially among underrepresented minority groups. Several barriers exist to minority group participation in clinical trial, one of which lack of awareness about clinical trials. Video educational programs show promise as an effective strategy to increase knowledge and clinical trial participation. The specific aims are as follows: 1. Measure the effects of an office-based, clinical trial education video on clinical trial knowledge and enrollment in clinical trials, in a clinical sample with no previous history of clinical trial participation. 2. Determine the feasibility of implementing an office-based video educational program.
Investigators
Consuelo H Wilkins
Executive Director of the Meharry-Vanderbilt Alliance, Associate Professor
Vanderbilt University Medical Center
Eligibility Criteria
Inclusion Criteria
- •Participants will be patients of Vanderbilt-Ingram Cancer Center (VICC) with a diagnosis of cancer Participants will have no previous history of clinical trial research participation
Exclusion Criteria
- •Previous history of clinical trial research participation
Outcomes
Primary Outcomes
study feasibility
Time Frame: 12 months
The stages of implementation completion (SIC) measure will be used as an internal tool utilized by the study team to track time to achievement of key implementation milestones. An 8-stage implementation plan to measure feasibility of the office-based educational program will be executed across 3 phases. Three scores will be derived from the SIC measure. The first score is the number of stages completed. The second score is the time spent at each stage. The third score is the proportion of activities completed at each stage. Implementation of the SIC model poses no additional burden on study participants.
Secondary Outcomes
- Clinical trial participation(12 months)
- Clinical trial knowledge survey(7-10 days)
- Likelihood to participate survey(7-10 days)